[Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002395:Catecholamines / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects* / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology*; D004357:Drug Synergism; D004569:Electroencephalography; D006339:Heart Rate / Q000187:drug effects; D006834:Hydrazines / Q000494:pharmacology*; D011817:Rabbits; D012119:Respiration / Q000187:drug effects
D002395:Catecholamines; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Potentialisation des effets centraux de la DOPA après inhibition sélective de la décarboxylase extracérébrale.